These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 36778904)
1. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary. Serajuddin ATM ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904 [TBL] [Abstract][Full Text] [Related]
2. Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction. Patel NG; Serajuddin ATM Int J Pharm; 2023 Feb; 632():122542. PubMed ID: 36566823 [TBL] [Abstract][Full Text] [Related]
3. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
4. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related]
5. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
6. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Alhijjaj M; Belton P; Qi S Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210 [TBL] [Abstract][Full Text] [Related]
7. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
8. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing. Zhang P; Xu P; Chung S; Bandari S; Repka MA Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460 [TBL] [Abstract][Full Text] [Related]
9. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production. Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253 [TBL] [Abstract][Full Text] [Related]
10. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution. Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418 [TBL] [Abstract][Full Text] [Related]
11. 3D-Printed Fast-Dissolving Oral Dosage Forms via Fused Deposition Modeling Based on Sugar Alcohol and Poly(Vinyl Alcohol)-Preparation, Drug Release Studies and In Vivo Oral Absorption. Ikeda S; Kobayashi M; Aoki S; Terukina T; Kanazawa T; Kojima H; Kondo H Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839717 [TBL] [Abstract][Full Text] [Related]
12. [Preparation and Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356 [TBL] [Abstract][Full Text] [Related]
13. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing. Chung S; Zhang P; Repka MA Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727 [TBL] [Abstract][Full Text] [Related]
14. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance. Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957 [TBL] [Abstract][Full Text] [Related]
15. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form. Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916 [TBL] [Abstract][Full Text] [Related]
16. Development of FDM 3D-printed tablets with rapid drug release, high drug-polymer miscibility and reduced printing temperature by applying the acid-base supersolubilization (ABS) principle. Patel NG; Serajuddin ATM Int J Pharm; 2021 May; 600():120524. PubMed ID: 33775724 [TBL] [Abstract][Full Text] [Related]
17. Enhanced Supersaturation via Fusion-Assisted Amorphization during FDM 3D Printing of Crystalline Poorly Soluble Drug Loaded Filaments. Buyukgoz GG; Kossor CG; Davé RN Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834272 [TBL] [Abstract][Full Text] [Related]
18. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment. Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676 [TBL] [Abstract][Full Text] [Related]
20. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing. Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]